Depression Management at the Workplace

Depression Clinical Trial

— DMW  

Official title:

Influencing Employer Purchasing Behavior

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01013220
• Other study ID #: R01MH076227
• Status: Completed
• Phase: N/A
• First received: November 12, 2009
• Last updated: December 15, 2014
• Start date: January 2009
• Est. completion date: September 2014

Study information

• Verified date: December 2014
• Source: Florida State University
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Interventional

Clinical Trial Summary

Randomized trials demonstrate that depression management products can improve clinical and organizational outcomes sufficiently for selected employers to realize a return on investment. Rather than usual care marketing which uses voltage-enhanced promises to sell voltage-diminished products, the investigators designed an evidence-based (EB) intervention to encourage employers to purchase a depression management product that offers the type, intensity and duration of care shown to provide clinical and organizational value. In an RCT designed to examine employer benefit purchasing behavior of depression products in 360 employer members of over 20 regional business coalitions, the research team proposes: (a) to compare the impact of evidence-based (EB) to usual care (UC) presentations on employer benefit purchasing behavior, and (b) to identify mediators and organizational moderators of intervention impact on employer benefit purchasing behavior.

This study addresses what policy analysts argue is one of the most pivotal problems in the translation of evidence-based care to 'real world' settings: whether purchasers can be influenced to buy health care products on the basis of value rather than cost. In the likely event that EB > UC, the study will provide encouragement to use an evidence-based approach to market new health care products to private payers on the basis of the product's clinical and organizational value. UC may achieve comparable outcomes to EB if the limiting factors in benefit purchasing are organizational, purchasing group and vendor constraints that no intervention can meaningfully modify. Support for this scenario would encourage the targeted marketing of new products to coalition members with empirically identified organizational, purchasing group and vendor characteristics, using usual care strategies.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 293
• Est. completion date: September 2014
• Est. primary completion date: September 2014
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Coalitions who belong to the National Business Coalition on Health are eligible if:

• they have 30+ employer purchasers/affiliates as members

• they act as more than purchasing agents

• (3)they did not participate in the research team's preliminary studies on this topic.

• Employers of participating coalitions are eligible if:

• they are a public or private organization providing health care benefits to 100+ domestic employees

• they have not purchased a depression management product in the past two years.

Exclusion Criteria:

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Health Services Research

Related Conditions & MeSH terms

• Depression
• Depressive Disorder

Intervention

Other:
• Depression Product Detailing
two hour academic detailing of depression management products to employees with responsibility for purchasing health care benefits technical assistance in purchasing high quality depression management products
• Depression HEDIS detailing
academic detailing to employees responsible for purchasing health care benefits on how to use HEDIS indicators for depression to assure their depressed employees receive high quality care for the condition technical assistance

Locations

Country	Name	City	State
United States	Colorado Business Group on Health	Denver	Colorado

Sponsors (3)

Lead Sponsor	Collaborator
Florida State University	Colorado Business Group on Health, University of South Florida

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	employer purchase of depression management product		two years after intervention	No
Secondary	fidelity of depression management model purchased to evidence-based models		two years after intervention	No

External Links

•   materials for academic detailing of depression management products